68 related articles for article (PubMed ID: 2196111)
1. Ras oncogene expression and progression in intraepithelial neoplasia of the uterine cervix.
Sagae S; Kudo R; Kuzumaki N; Hisada T; Mugikura Y; Nihei T; Takeda T; Hashimoto M
Cancer; 1990 Jul; 66(2):295-301. PubMed ID: 2196111
[TBL] [Abstract][Full Text] [Related]
2. Oncogene expression in cervical intraepithelial neoplasia and invasive cancer of cervix.
Pinion SB; Kennedy JH; Miller RW; MacLean AB
Lancet; 1991 Apr; 337(8745):819-20. PubMed ID: 1672915
[TBL] [Abstract][Full Text] [Related]
3. ras oncogene expression and prognosis of invasive squamous cell carcinomas of the uterine cervix.
Sagae S; Kuzumaki N; Hisada T; Mugikura Y; Kudo R; Hashimoto M
Cancer; 1989 Apr; 63(8):1577-82. PubMed ID: 2647277
[TBL] [Abstract][Full Text] [Related]
4. Expression of ras, c-myc, and p53 proteins in cervical intraepithelial neoplasia.
Slagle BL; Kaufman RH; Reeves WC; Icenogle JP
Cancer; 1998 Oct; 83(7):1401-8. PubMed ID: 9762942
[TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors].
Yaginuma Y; Yamashita K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of p21H-ras expression and H-ras codon 12 mutation in squamous intraepithelial lesion (SIL) and carcinoma of uterine cervix].
Li X; Jiao S; Mi R
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):306-8. PubMed ID: 11038767
[TBL] [Abstract][Full Text] [Related]
7. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
[TBL] [Abstract][Full Text] [Related]
8. MIB 1 immunostaining in cervical intraepithelial neoplasia: prognostic significance in mild and moderate lesions.
Garzetti GG; Ciavattini A; De Nictolis M; Lucarini G; Goteri G; Romanini C; Biagini G
Gynecol Obstet Invest; 1996; 42(4):261-6. PubMed ID: 8979100
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD44 in uterine cervical squamous neoplasia: a predictor of microinvasion?
Callagy G; O'Grady A; Butler D; Leader M; Kay E
Gynecol Oncol; 2000 Jan; 76(1):73-9. PubMed ID: 10620445
[TBL] [Abstract][Full Text] [Related]
10. ras oncogene product p21 expression and prognosis of human ovarian tumors.
Yaginuma Y; Yamashita K; Kuzumaki N; Fujita M; Shimizu T
Gynecol Oncol; 1992 Jul; 46(1):45-50. PubMed ID: 1634140
[TBL] [Abstract][Full Text] [Related]
11. Correlation between the expression of the P21 ras oncogene product and the biological behavior of bladder tumors.
Miao TJ; Wang Z; Sang N
Eur Urol; 1991; 20(4):307-10. PubMed ID: 1814747
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of ras oncogene expression in endometrial and cervical human lesions.
Agnantis NJ; Spandidos DA; Mahera H; Parissi P; Kakkanas A; Pintzas A; Papacharalampous NX
Eur J Gynaecol Oncol; 1988; 9(5):360-5. PubMed ID: 3066621
[TBL] [Abstract][Full Text] [Related]
13. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; GarcĂa Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotype of mutant ras p21 and early response to radiotherapy in cancer of the uterine cervix.
Sreelekha TT; Nair MK; Jayaprakash PG; Pillai MR
J Exp Clin Cancer Res; 1999 Sep; 18(3):337-41. PubMed ID: 10606179
[TBL] [Abstract][Full Text] [Related]
15. Analysis of ras gene expression in stomach cancer by anti-ras p21 monoclonal antibodies.
Yoshida K; Hamatani K; Koide H; Abe Y; Ikeda H; Tsuchiyama H; Nakayama E; Shiku H
Cancer Detect Prev; 1988; 12(1-6):369-76. PubMed ID: 3052835
[TBL] [Abstract][Full Text] [Related]
16. Ras p21 immunostaining in early stage squamous cervical carcinoma: relationship with lymph nodal involvement and 72 kDa-metalloproteinase index.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Nictolis MD; Romanini C; Biagini G
Anticancer Res; 1998; 18(1B):609-13. PubMed ID: 9568185
[TBL] [Abstract][Full Text] [Related]
17. ras and c-myc oncoproteins during tumor progression in the uterine cervix.
Nair SA; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
Tumori; 1998; 84(5):583-8. PubMed ID: 9862521
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of the ras oncogene expression in human bladder endoscopy specimens.
Agnantis NJ; Constantinidou A; Poulios C; Pintzas A; Kakkanas A; Spandidos DA
Eur J Surg Oncol; 1990 Apr; 16(2):153-60. PubMed ID: 2182341
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance on expression of the ras gene product P21 in human cervical carcinoma tissues].
Huang G; Lu S; Mao T; Song Y
Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):61-4. PubMed ID: 1398628
[TBL] [Abstract][Full Text] [Related]
20. Expression of ras oncogene p21 protein in esophageal squamous cell carcinoma.
Ruol A; Stephens JK; Michelassi F; Segalin A; Chiarelli S; Peracchia A; Skinner DB; Little AG
J Surg Oncol; 1990 Jul; 44(3):142-5. PubMed ID: 2196399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]